Skip to content
OpenCapital
Get started

Haemonetics HAE Net debt / EBITDA

Net debt / EBITDA at other companies

Abbott logo
AbbottABT
2.5×+1.9×
TFX
TeleflexTFX
8.5×+4.3×
Boston Scientific logo
Boston ScientificBSX
-0.1×-2.9×
Medtronic logo
MedtronicMDT
2.9×-0.2×
LivaNova logo
LivaNovaLIVN
-0.8×-2.1×
ICU Medical logo
ICU MedicalICUI
4.4×-0.5×

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
Enterprise value$4.4B-12.5%
P/S2.5×-0.5×

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

net debt/ebitda=2.4×

Based on the most recent quarter.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's net debt / EBITDA?
Haemonetics (HAE) reported net debt / EBITDA of 2.4× in Q4 2025.
How has Haemonetics's net debt / EBITDA changed year-over-year?
Haemonetics's net debt / EBITDA decreased by 22.6% year-over-year, from 3.1× to 2.4×.
What is the long-term trend for Haemonetics's net debt / EBITDA?
Over 4 years (2021 to 2025), Haemonetics's net debt / EBITDA has grown at a -3.7% compound annual growth rate (CAGR), from 3.4× to 2.9×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.